VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation. Left atrial appendage occlusion (LAAO) placement is associated with a reduced risk for ...

The current bias of medicine is strong. When we are in doubt, when evidence is sparse, doctors do more, not less. Internists prescribe, cardiologists implant, surgeons cut. We know what we know. So it ...

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and remains a significant contributor to morbidity and mortality worldwide. A central focus of current research is the left ...

Medtronic (NYSE:MDT) reported new positive post-market clinical evidence for its Penditure left atrial appendage (LAA) ...

No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...

Chicago, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The global left atrial appendage closure devices market was valued at 1.98 billion in 2024 and is expected to reach US$ 9.40 billion by 2033, growing at a ...